Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Ramazi S et al. | 2023 | intact cell/cell culture, MCF-7 (human breast cancer cell line) and HFF cells (human foreskin fibroblast cells) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
Reipert BM et al. | 1997 | intact cell/cell culture, FDCP-mix(A4) cell line (mouse bone marrow cells) | magnetic field, static magnetic field, 50/60 Hz, shielding/field deprivation | 0.2 µT–2 mT |
Robison JG et al. | 2002 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells), HL-60R (human acute myeloid leukaemia cells with retinoic acid receptor-alhpa gene mutation) and Raji cells (human Burkitt lymphoma cells) | magnetic field, 50/60 Hz | 150 µT |
Roushangar L et al. | 2007 | animal, rat/Wistar | magnetic field, 50/60 Hz | 3 mT |
Saha S et al. | 2014 | animal, mouse/C57BL/6, whole body: <i>in utero</i> | magnetic field, 50/60 Hz, also other exposures without EMF | 100–300 µT |
Sanie-Jahromi F et al. | 2018 | - | 50/60 Hz, magnetic field, co-exposure | - |
Santini MT et al. | 2003 | intact cell/cell culture, human osteosarcoma cell lines (MG-63 and Saos-2) | magnetic field, 50/60 Hz | 500 µT |
Santini MT et al. | 2005 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz | 1–5 mT |
Schimmelpfeng J et al. | 1997 | intact cell/cell culture, SV40-swiss-3T3 cells (mouse fibroblast cell line) and HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 2 mT |
Simko M et al. | 1998 | intact cell/cell culture, AFC cells (human amniotic fluid cell line) and SCL II cells (human squamous cell carcinoma cell line) | magnetic field, 50/60 Hz | 1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.